Claudins 1, 4, 5, 7 and occludin in ameloblastomas and developing human teeth

Journal of Oral Pathology and Medicine

Volumn 36, Issue 1, 2007, Pages 48-54

  Bello, Ibrahim O ^a,b,c   Soini, Ylermi ^a,b   Slootweg, Pieter J ^d   Salo, Tuula ^a,b  

^a UNIVERSITY OF OULU   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF IBADAN   (Nigeria)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Ameloblastic carcinoma; Ameloblastoma; Claudin; Human tooth germ; Immunohistochemistry; Occludin

Indexed keywords

CLAUDIN 1; CLAUDIN 4; CLAUDIN 5; CLAUDIN 7; OCCLUDIN; PARAFFIN; PROTEIN ANTIBODY;

AMELOBLAST; AMELOBLASTOMA; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENAMEL; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SQUAMOUS CELL; STAINING; TOOTH DEVELOPMENT; TOOTH FLORA;

AMELOBLASTOMA; AMELOBLASTS; AMELOGENESIS; CELL DIFFERENTIATION; DENTAL ENAMEL; ENAMEL ORGAN; EPITHELIUM; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; ODONTOGENESIS; PARAFFIN EMBEDDING; TIGHT JUNCTIONS; TOOTH GERM;

EID: 33845741994     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2006.00497.x     Document Type: Article

References (26)

1. Schneeberger EE, Lynch RD. The tight junction: a multifunctional complex. Am J Physiol Cell Physiol 2004; 286: C1213-28.
2. Tsukita S, Furuse M. Claudin based barrier in simple and stratified cellular sheets. Curr Opin Cell Biol 2002; 14: 531-6.
3. Diamond JM. Twenty-First Bowditch Lecture. The epithelial junction: bridge, gate, and fence. Physiologist 1977; 20: 10-8.
4. Gonzalez-Mariscal L, Betanzos A, Nava P, Jaramillo BE. Tight junction proteins. Prog Biophys Mol Biol 2003; 81: 1-44.
5. Bazzoni G. The JAM family of junctional adhesion molecules. Curr Opin Cell Biol 2003; 15: 525-30.
6. Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2001; 2: 285-93.
7. Mitic LL, van Itallie CM, Anderson JM. Molecular physiology and pathophysiology of tight junctions: I. Tight junction structure and function: lesions from mutant animals and proteins. Am J Physiol Gastrointest Liver Physiol 2000; 279: G250-4.
8. Barrios-Rodiles M, Brown KR, Ozdamar B, et al. High-throughput mapping of a dynamic signalling network in mammalian cells. Science 2005; 307: 1621-5.
9. Turksen K, Troy T-C. Barriers built on claudins. J Cell Sci 2004; 117: 2435-47.
10. Rahner C, Mitic LL, Anderson JM. Heterogeneity in expression and subcellular localization of claudins 2, 3, 4, and 5 in the rat liver, pancreas, and gut. Gastroenterology 2001; 120: 411-22.
11. Regezi JA, Kerr DA, Courtney RM. Odontogenic tumours: analysis of 706 cases. J Oral Surg 1978; 36: 771-8.
12. Small IA, Waldron CA. Ameloblastoma of the jaws. Oral Surg Oral Med Oral Pathol 1955; 8: 281-97.
13. Soini Y. Expression of claudins 1, 2, 3, 4, 5 and 7 in various types of tumours. Histopathology 2005; 46: 551-60.
14. Soini Y. Claudin 2, 3, 4 and 5 in Paget's disease and breast carcinoma. Hum Pathol 2004; 35: 1531-6.
15. Kominsky SL, Vali M, Korz D, et al. Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4. Am J Pathol 2004; 164: 1627-33.
16. Hough CD, Sherman-Baust CA, Pizer ES, et al. Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res 2000; 60: 6281-7.
17. Kominsky SL, Argani P, Korz D, et al. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 2003; 22: 2021-33.
18. Soini Y, Tommola S, Helin H, Martikainen P. Claudins 1, 3, 4, and 5 in gastric carcinoma, loss of claudin expression associates with diffuse subtype. Virchows Arch 2006; 448: 52-8.
19. Al Moustafa AE, Alaoui-Jamali MA, Batist G, et al. Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells. Oncogene 2002; 21: 2634-40.
20. Sobel G, Paska C, Szabo I, Kiss A, Kadar A, Schaff Z. Increased expression of claudins in cervical squamous intraepithelial neoplasia and invasive carcinoma. Hum Pathol 2005; 36: 162-9.
21. Lee JW, Lee SJ, Seo J, et al. Increased expressions of claudin-1 and claudin-7 during the progression of cervical neoplasia. Gynecol Oncol 2005; 97: 53-9.
22. Morita K, Tsukita S, Miyachi Y. Tight junction-associated proteins (occludin, ZO-1, claudin-1, claudin-4) in squamous cell carcinoma and Bowen's disease. Br J Dermatol 2004; 151: 328-34.
23. Salo T, Kainulainen T, Parikka M, Heikinheimo K. Expression of laminin-5 in ameloblastomas and human teeth. J Oral Pathol Med 1999; 28: 337-42.
24. Väänänen A, Tjaderhane L, Eklund L, et al. Expression of collagen XVIII and MMP-20 in developing teeth and odontogenic tumors. Matrix Biol 2004; 23: 153-61.
25. Pirilä E, Sharabi A, Salo T, et al. Matrix metalloproteinases process the laminin-5 gamma2-chain and regulate epithelial cell migration. Biochem Biophys Res Commun 2003; 303: 1012-7.
26. Oku N, Sasabe E, Ueta E, Yamamamoto T, Osaki T. Tight junction protein claudin-1 enhances the invasive activity of oral squamous cell carcinoma cells by promoting cleavage of laminin-5 gamma2 chain via matrix metalloproteinase (MMP)-2 and membrane-type MMP-1. Cancer Res 2006; 66: 5251-7.